- Home
- MERC vs CDXS Comparison
MERC vs CDXS Comparison
Compare MERC & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- CDXS
- Stock Information
- Founded
- MERC 1968
- CDXS 2002
- Country
- MERC Canada
- CDXS United States
- Employees
- MERC N/A
- CDXS N/A
- Industry
- MERC Paper
- CDXS Major Chemicals
- Sector
- MERC Basic Materials
- CDXS Industrials
- Exchange
- MERC Nasdaq
- CDXS Nasdaq
- Market Cap
- MERC 271.5M
- CDXS 254.3M
- IPO Year
- MERC 1987
- CDXS 2010
- Fundamental
- Price
- MERC $3.05
- CDXS $2.35
- Analyst Decision
- MERC Hold
- CDXS Buy
- Analyst Count
- MERC 3
- CDXS 2
- Target Price
- MERC $4.67
- CDXS $11.00
- AVG Volume (30 Days)
- MERC 484.3K
- CDXS 1.0M
- Earning Date
- MERC 10-30-2025
- CDXS 10-30-2025
- Dividend Yield
- MERC 9.74%
- CDXS N/A
- EPS Growth
- MERC N/A
- CDXS N/A
- EPS
- MERC N/A
- CDXS N/A
- Revenue
- MERC $1,951,044,000.00
- CDXS $57,164,000.00
- Revenue This Year
- MERC N/A
- CDXS $12.88
- Revenue Next Year
- MERC $13.33
- CDXS $21.64
- P/E Ratio
- MERC N/A
- CDXS N/A
- Revenue Growth
- MERC N/A
- CDXS N/A
- 52 Week Low
- MERC $2.59
- CDXS $1.90
- 52 Week High
- MERC $8.28
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- MERC 42.99
- CDXS 34.52
- Support Level
- MERC $3.07
- CDXS $2.38
- Resistance Level
- MERC $3.29
- CDXS $2.54
- Average True Range (ATR)
- MERC 0.14
- CDXS 0.12
- MACD
- MERC 0.00
- CDXS -0.01
- Stochastic Oscillator
- MERC 5.71
- CDXS 12.00
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.